Patients using Remicade (infliximab) for rheumatoid arthritis or Crohn's now...watched for heart failure
December 2001
Patients using Remicade (infliximab) for rheumatoid arthritis or Crohn's now need to be watched for heart failure.
This is because of a higher incidence of mortality and worsening heart failure when Remicade is given to patients with moderate to severe heart failure.
This is a surprise.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote